Overall, our data from transgenic mice experiments complement our findings from cell line models and clinical breast cancer samples, strongly supporting the role of FAF1 as a metastasis-suppressing gene via the direct targeting of TβRII. This evidence concerns the gene TGFBR2 and breast carcinoma.